MyAverix Finance
F · Healthcare
RECCE PHARMACEUTICALS LTD (R9Q)
Biotechnology
RECCE PHARMACEUTICALS LTD (R9Q) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $74.03M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for R9Q
RECCE PHARMACEUTICALS LTD (R9Q) — FAQ
What is RECCE PHARMACEUTICALS LTD's market cap?
RECCE PHARMACEUTICALS LTD (R9Q) has a reported market cap of $74.03M (data as of 2026-03-30).
What is R9Q's P/E ratio?
The price-to-earnings (P/E) ratio for RECCE PHARMACEUTICALS LTD (R9Q) is 18.00 (data as of 2026-03-30).
Does RECCE PHARMACEUTICALS LTD pay a dividend?
Dividend yield is not available in the current snapshot for RECCE PHARMACEUTICALS LTD (R9Q). Check the MyAverix Finance app for the latest dividend data.
What sector is RECCE PHARMACEUTICALS LTD in?
RECCE PHARMACEUTICALS LTD (R9Q) is classified in the Healthcare sector (Biotechnology industry).
What exchange is R9Q listed on?
R9Q is listed on F.
What is RECCE PHARMACEUTICALS LTD's net margin?
RECCE PHARMACEUTICALS LTD (R9Q) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.